Delivery Order SPE2DB20D1109-SPE2DB24FP70L
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The $85,266.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 12, 2022. The contract has an ultimate completion date of August 15, 2022 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to support the Defense Logistics Agency's (DLA) medical supply needs. The $9,803.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024, with an ultimate completion date of November 5, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed price of $7,496.71 and an ultimate completion date of August 15, 2023. It was awarded on August 14, 2023 and does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 18, 2024, with a completion date of December 19, 2024. The contract has a firm fixed-price of $11,664.53 and is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
The federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $12,029.82, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The $6,694.17 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for the...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 19, 2024 with a ceiling value of $24,990.93 and a completion date of July 22, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,837.84 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with an ultimate completion date of December 3, 2024. The award is issued under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,343.72 firm fixed-price contract has a completion date of February 14, 2024 and was awarded on February 13, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Dupixent 300 mg/2 mL syringes to support U.S. government healthcare programs. The $10,198.24 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of November 9, 2023 and does not include any set-aside requirements, indicating full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company...